Shares of Veren Inc. (TSE:VRN – Get Free Report) traded up 15.9% on Monday . The stock traded as high as C$8.39 and last traded at C$8.18. 14,926,928 shares were traded during mid-day trading, an increase of 246% from the average session volume of 4,314,159 shares. The stock had previously closed at C$7.06.
Analyst Ratings Changes
A number of equities analysts have recently commented on VRN shares. National Bankshares lifted their target price on shares of Veren from C$12.50 to C$13.00 and gave the company an “outperform” rating in a report on Thursday, January 30th. CIBC lowered their price objective on shares of Veren from C$13.00 to C$12.50 in a research report on Friday, January 17th. Six research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of C$11.83.
Read Our Latest Analysis on Veren
Veren Stock Performance
Veren Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Tuesday, April 1st will be paid a $0.115 dividend. The ex-dividend date is Friday, March 14th. This represents a $0.46 dividend on an annualized basis and a yield of 5.62%.
Veren Company Profile
Veren Inc explores, develops, and produces oil and gas properties in Canada and the United States. The company focuses on crude oil, tight oil, natural gas liquids, shale gas, and natural gas reserves. Its properties are located in the provinces of Saskatchewan, Alberta, British Columbia, and Manitoba; and the states of North Dakota.
Featured Articles
- Five stocks we like better than Veren
- What Does Downgrade Mean in Investing?
- How to Protect Your Portfolio When Inflation Is Rising
- 3 Healthcare Dividend Stocks to Buy
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Veren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veren and related companies with MarketBeat.com's FREE daily email newsletter.